Quoin Pharmaceuticals Ltd DRC share price logo

Quoin Pharmaceuticals Ltd DRC

NASDAQ: QNRX

Small Cap

$6.45

+0.52

(+8.77%)

as on

Quoin Pharmaceuticals Ltd DRC Stock Performance

as on May 1, 2026 at 6:56 am IST

  • Day's Low

    Day's High

    $5.79
    $6.53
    downward going graph

    10.23%

    Downside

    1.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.20
    $41.80
    downward going graph

    19.38%

    Downside

    548.06%

    Upside

    downward going graph

Quoin Pharmaceuticals Ltd DRC share price movements today

Previous Close
$5.93
Open
$5.93
Volume
135.2K
Day's Low - High
$5.79 - $6.53
52 Week Low - High
$5.20 - $41.80

Quoin Pharmaceuticals Ltd DRC Historical Returns

1 Month Return
-5.57 %
3 Month Return
-17.81 %
1 Year Return
-12.39 %
3 Year Return
-97.18 %
5 Year Return
0 %

Quoin Pharmaceuticals Ltd DRC Stock Fundamentals & Key Indicators

Check Quoin Pharmaceuticals Ltd DRC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.8M

EPS (TTM)

-5.55

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-16.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-141.59%

Quoin Pharmaceuticals Ltd DRC vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Quoin Pharmaceuticals Ltd DRC with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$9.8MNANA0.00%
BUY$40.2B114.16%129.828.45%
BUY$109.4B93.97%28.132.94%
NA$32.3BNA117.735.37%
BUY$76.7B42.61%17.6431.41%

Stock Returns calculator for Quoin Pharmaceuticals Ltd DRC Stock including INR - Dollar returns

The Quoin Pharmaceuticals Ltd DRC stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Quoin Pharmaceuticals Ltd DRC investment value today

Current value as on today

₹1,06,886

Returns

₹6,886

(+6.89%)

Returns from Quoin Pharmaceuticals Ltd DRC Stock

-₹4,727 (-4.73%)

Dollar Impact

₹11,613 (+11.61%)

Analyst Recommendation on Quoin Pharmaceuticals Ltd DRC Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Quoin Pharmaceuticals Ltd DRC. Average target price of $29.67

Quoin Pharmaceuticals Ltd DRC Share Price Target

Get share price movements and forecasts by analysts on Quoin Pharmaceuticals Ltd DRC.

What analysts predicted

78.26%UPSIDE

Target Price

$29.67

Current Price

$6.45

Analyzed by

8 Analysts

Target

$29.67

Quoin Pharmaceuticals Ltd DRC target price $29.67, a slight upside of 78.26% compared to current price of $6.45. According to 8 analysts rating.

Quoin Pharmaceuticals Ltd DRC Stock’s Investor Sentiment and Interest

Search interest for Quoin Pharmaceuticals Ltd DRC Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:12% versus previous 30 day period

Quoin Pharmaceuticals Ltd DRC Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
-
-
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
-
0
Operating Income
-2
-2
-2
-2
-2
-2
-3
-3
-4
-4
EBITDA
-2
-2
-2
-2
-2
-2
-3
-3
-3
-4
Interest Expense
-
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-2
-2
-1
-2
-2
-3
-3
-3
-4
Income Tax Expense
0
2
0
1
-8,953
-1
-
-
-
-
Net Income
-1
-2
-2
-1
-2
-2
-3
-3
-3
-15,793
Net Profit Margin
0.00%
-1324.43%
0.00%
0.00%
0.00%
-2302.75%
0.00%
0.00%
0.00%
0.00%

Quoin Pharmaceuticals Ltd DRC Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
15
15
-1
-1
-6
-9
-9
-9
-16
EBITDA
15
15
-1
-1
-20
-8
-9
-9
-16
Interest Expense
-
-
0
1
1
0
-
-
-
Depreciation
-
-
0
0
0
0
0
0
0
Income Before Tax
15
15
-1
-2
-21
-9
-8
-8
-15
Income Tax Expense
0
0
1
0
-12
0
0
-8,953
-
Net Income
15
15
-1
-2
-21
-9
-8
-8
-15,804
Net Profit Margin
-5470.36%
-5470.36%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Quoin Pharmaceuticals Ltd DRC Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-2
-2
-1
-2
-2
-3
-3
-3
-15,793
Operating Cash Flow
-3
-1
-2
-2
-2
-2
-3
-2
-5
Investing Cash Flow
2
-4
3
2
-3
2
1
2
-11
Financing Cash Flow
0
5
0
0
5
0
0
0
18
Change in Cash
0
0
1
0
0
0
-2
0
1

Quoin Pharmaceuticals Ltd DRC Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-5
-4
-2
-21
-9
-8
-9
-15,804
Operating Cash Flow
-4
-6
-5
-1
-5
-8
-7
-7
-13,540
Investing Cash Flow
2
3
0
0
0
-10
2
-1
-4,277
Financing Cash Flow
4
3
6
1
13
14
5
10
18,014
Change in Cash
2
0
0
-4
7
-4
0
1
194

Global Institutional Holdings in Quoin Pharmaceuticals Ltd DRC

Funds
Holdings
Soleus Capital Management, L.P.
1.39%
SummitTX Capital, L.P
3.59%
Morgan Stanley - Brokerage Accounts
0%
Millennium Management LLC
4.15%
Altium Capital Management, LP
0%

Quoin Pharmaceuticals Ltd DRC News & Key Events

  • img

    Today's Timeline - 21 October

    Tue, 06:07 PM

    -

    Quoin Pharmaceuticals announces FDA grants Orphan Drug Designation for QRX003 to treat Netherton Syndrome.

Insights on Quoin Pharmaceuticals Ltd DRC

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Quoin Pharmaceuticals Ltd has experienced a drawdown of -97.2%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 82.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 14.6% return, outperforming this stock by 27.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, QNRX stock has moved down by -97.2%

About Quoin Pharmaceuticals Ltd DRC

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
OrganisationQuoin Pharmaceuticals Ltd DRC
Headquarters42127 Pleasant Forest Court, Ashburn, VA, United States, 20148-7349
IndustryBiotechnology
CEODr. Michael Myers Ph.D.
E-voting on sharesClick here to vote

Key Management of Quoin Pharmaceuticals Ltd DRC

Name

Title

Dr. Michael Myers Ph.D.

Co-Founder, CEO & Chairman

Ms. Denise Carter

Co-Founder, COO & Director

Ms. Sally Lawlor

Chief Financial Officer

FAQs

What is Quoin Pharmaceuticals Ltd DRC share price today?

Quoin Pharmaceuticals Ltd DRC share price today is $6.45 as on at the close of the market. Quoin Pharmaceuticals Ltd DRC share today touched a day high of $6.53 and a low of $5.79.

What is the 52 week high and 52 week low for Quoin Pharmaceuticals Ltd DRC share?

Quoin Pharmaceuticals Ltd DRC share touched a 52 week high of $41.8 on and a 52 week low of $5.2 on . Quoin Pharmaceuticals Ltd DRC stock price today i.e. is closed at $6.45,which is 84.57% down from its 52 week high and 24.04% up from its 52 week low.

What is Quoin Pharmaceuticals Ltd DRC's market capitalisation today?

Quoin Pharmaceuticals Ltd DRC market capitalisation is $0.00T as on .

How to invest in Quoin Pharmaceuticals Ltd DRC Stock (QNRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Quoin Pharmaceuticals Ltd DRC on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Quoin Pharmaceuticals Ltd DRC Shares that will get you 0.2326 shares as per Quoin Pharmaceuticals Ltd DRC share price of $6.45 per share as on May 1, 2026 at 1:26 am IST.

What is the minimum amount required to buy Quoin Pharmaceuticals Ltd DRC Stock (QNRX) from India?

Indian investors can start investing in Quoin Pharmaceuticals Ltd DRC (QNRX) shares with as little as ₹94.91 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Quoin Pharmaceuticals Ltd DRC stock (as per the Rupee-Dollar exchange rate as on ). Based on Quoin Pharmaceuticals Ltd DRC share’s latest price of $6.45 as on May 1, 2026 at 1:26 am IST, you will get 1.5504 shares of Quoin Pharmaceuticals Ltd DRC. Learn more about fractional shares .